🇺🇸 FDA
Patent

US 8901141

Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them

granted A61KA61K31/4188A61K31/519

Quick answer

US patent 8901141 (Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them) held by Takeda Pharmaceutical Company Limited expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/4188, A61K31/519, A61P, A61P25/00